REFERENCES

1. Matsui H, Iitsuka Y, Yamazawa K, Tanaka N, Seki K, Sekiya S. Changes in the incidence of molar pregnancies. A population-based study in Chiba Prefecture and Japan between 1974 and 2000.

2. Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med 1998;43:60-68.

3. Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995;86:775-79.

4. Benson CB, Genest DR, Bernstein MR, Soto- Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 2000;16:188-91.

5. Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 2006;27:56-60.

6. Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hy­dropic abortions. Histopathology 1996;28:101-10.

7. Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of par­tial and complete hydatidiform mole in the first trimester of preg­nancy. Pediatr Dev Pathol 2003;6:69-77.

8. Tidy JA, Gillespie AM, Bright N, Radstone CR, Coleman RE, Hancock BW Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 2000;78:309-12.

9. Cole LA, Butler S. Detection of hCG in trophoblastic dis­ease. The USA hCG reference service experience. J Reprod Med 2002;7:433-44.

10. Cole LA. Phantom hCG and phantom choriocarcinoma. Gynecol Oncol 1998;71:325-29.

11. Costa HL, Doyle P. Influence of oral contraceptives in the devel­opment of post-molar trophoblastic neoplasia—a systematic re­view.

12. Royal College of Obstetricians and Gynaecologists (RCOG). The Management of Gestational Trophoblastic Disease, Green-top Guideline No. 38. London: RCOG; 2010.

13. Eagles N, Sebire NJ, Short D, Savage PM, Seckl MJ, Fisher RA. Risk of recurrent molar pregnancies following complete and par­tial hydatidiform moles. Hum Reprod 2015;30:2055-63.

14. Parazzini F, Mangili G, Belloni C, La Vecchia C, Liati P, Marabini R. The problem of identification of prognostic factors for per­sistent trophoblastic disease. Gynecol Oncol 1988;30:57-62.

15. Sebire NJ, Foskett M, Paradinas FJ, et al. Outcome of twin preg­nancies with complete hydatidiform mole and healthy co-twin. Lancet 2002;359:2165-66.

16. FIGO Oncology Committee. FIGO staging for gestational tropho­blastic neoplasia 2000. Int J Gynaecol Obstet 2002;77:285-87.

17. Hancock BW, Welch EM, Gillespie AM, Newlands ES. A retro­spective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. Int J Gynecol Cancer 2000;10:318-22.

18. Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA. First- line chemotherapy in low- risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012;7:CD007102.

19. Lybol C, Sweep FC, Harvey R, et al. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-r isk gestational trophoblastic neoplasia. Gynecol Oncol 2012;125:576-79.

20. Sita-Lumsden A, Short D, Lindsay I, et al. Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009. Br J Cancer 2012;107:1810-14.

21. Bower M, Newlands ES, Holden L, et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 pa­tients. J Clin Oncol 1997;15:2636-43.

22. Deng L, Zhang J, Wu T, Lawrie TA. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tu­mour. Cochrane Database Syst Rev 2013; 1 :CD005196.

23. Alifrangis C, Agarwal R, Short D, et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induc­tion low-dose etoposide-cisplatin and genetic analysis. J Clin Oncol 2013;31:280-86.

24. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic dis­ease. Lancet 2010;376:717-29.

25. Powles T, Savage PM, Stebbing J, et al. A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer 2007;96:732-37.

26. Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;18:854-59.

27. Ngan HY, Tam KF, Lam KW, Chan KK. Methotrexate, bleomycin, and etoposide in the treatment of gestational trophoblastic neo­plasia. Obstet Gynecol 2006;107:1012-17.

28. Song SQ, Wang C, Zhang GN, et al. BEP for high-risk gestational trophoblastic tumor: results from a cohort of 45 patients. Eur J Gynaecol Oncol 2015;36:726-29.

29. Newlands ES, Holden L, Seckl MJ, McNeish I, Strickland S, Rustin GJ. Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:465-71.

30. Suzuka K, Matsui H, Iitsuka Y, Yamazawa K, Seki K, Sekiya S. Adjuvant hysterectomy in low-risk gestational trophoblastic dis­ease. Obstet Gynecol 2001;97:431-34.

31. Jones WB, Romain K, Erlandson RA, Burt ME, Lewis JL Jr. Thoracotomy in the management of gestational choriocarcinoma. A clinicopathologic study. Cancer 1993;72:2175-81.

32. McGrath S, Harding V, Lim AK, Burfitt N, Seckl MJ, Savage P. Embolization of uterine arteriovenous malformations in pa­tients with gestational trophoblastic tumors: a review of pa­tients at Charing Cross Hospital, 2000-2009. J Reprod Med 2012;57:319-24.

33. Keepanasseril A, Suri V, Prasad GR, et al. Management of massive hemorrhage in patients with gestational trophoblastic neoplasia by angiographic embolization: a safer alternative. J Reprod Med 2011;56:235-40.

34. Piura E, Piura B. Brain metastases from gestational trophoblastic neoplasia: review of pertinent literature. Eur J Gynaecol Oncol 2014;35:359-67.

35. Barnard DE, Woodward KT, Yancy SG, Weed JC Jr, Hammond CB. Hepatic metastases of choriocarcinoma: a report of 15 pa­tients. Gynecol Oncol 1986;25:73-85.

36. Matsui H, Iitsuka Y, Suzuka K, et al. Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor. Gynecol Oncol 2003;88:104-107.

37. Blagden SP, Foskett MA, Fisher RA, et al. The effect of early preg­nancy following chemotherapy on disease relapse and foetal out­come in women treated for gestational trophoblastic tumours. Br J Cancer 2002;86:26-30.

38. Woolas RP, Bower M, Newlands ES, Seckl M, Short D, Holden L. Influence of chemotherapy for gestational trophoblastic dis­ease on subsequent pregnancy outcome. Br J Obstet Gynaecol 1998;105:1032-35.

39. Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R. Gestational trophoblastic diseases: 3. Human chori­onic gonadotropin-free beta-subunit, a reliable marker of pla­cental site trophoblastic tumors. Gynecol Oncol 2006;102:160-64.

40. Schmid P, Nagai Y, Agarwal R, et al. Prognostic markers and long­term outcome of placental-site trophoblastic tumours: a retro­spective observational study. Lancet 2009;374:48-55.

41. Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic dis­ease after an initial diagnosis of partial hydatidiform mole: geno­typing and chromosome in situ hybridization analysis. Cancer 2004;100:1411-17.